| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | zinc ion binding | 1.16e-05 | 891 | 26 | 8 | GO:0008270 | |
| GeneOntologyMolecularFunction | transition metal ion binding | 9.18e-05 | 1189 | 26 | 8 | GO:0046914 | |
| GeneOntologyMolecularFunction | modification-dependent protein binding | 1.38e-04 | 206 | 26 | 4 | GO:0140030 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein reader activity | 4.80e-04 | 25 | 26 | 2 | GO:0140035 | |
| GeneOntologyMolecularFunction | nuclear receptor activity | 2.75e-03 | 60 | 26 | 2 | GO:0004879 | |
| GeneOntologyMolecularFunction | ligand-activated transcription factor activity | 2.85e-03 | 61 | 26 | 2 | GO:0098531 | |
| GeneOntologyMolecularFunction | 2-oxoglutarate-dependent dioxygenase activity | 3.22e-03 | 65 | 26 | 2 | GO:0016706 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | 1.52e-05 | 999 | 25 | 8 | GO:0071824 | |
| GeneOntologyBiologicalProcess | negative regulation of cell cycle phase transition | 3.13e-05 | 311 | 25 | 5 | GO:1901988 | |
| GeneOntologyBiologicalProcess | negative regulation of cell cycle process | 6.44e-05 | 362 | 25 | 5 | GO:0010948 | |
| GeneOntologyBiologicalProcess | chromatin organization | 6.89e-05 | 896 | 25 | 7 | GO:0006325 | |
| GeneOntologyBiologicalProcess | cell cycle phase transition | 8.33e-05 | 627 | 25 | 6 | GO:0044770 | |
| GeneOntologyBiologicalProcess | hormone-mediated signaling pathway | 1.99e-04 | 244 | 25 | 4 | GO:0009755 | |
| GeneOntologyBiologicalProcess | negative regulation of cell cycle | 2.06e-04 | 464 | 25 | 5 | GO:0045786 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle phase transition | 3.37e-04 | 516 | 25 | 5 | GO:1901987 | |
| GeneOntologyCellularComponent | synaptonemal structure | 1.49e-03 | 46 | 26 | 2 | GO:0099086 | |
| GeneOntologyCellularComponent | synaptonemal complex | 1.49e-03 | 46 | 26 | 2 | GO:0000795 | |
| MousePheno | abnormal cell cycle | 4.61e-07 | 520 | 21 | 8 | MP:0003077 | |
| MousePheno | increased classified tumor incidence | 8.84e-07 | 381 | 21 | 7 | MP:0010273 | |
| MousePheno | abnormal classified tumor incidence | 9.32e-07 | 384 | 21 | 7 | MP:0020188 | |
| MousePheno | increased T cell derived lymphoma incidence | 1.05e-06 | 53 | 21 | 4 | MP:0002024 | |
| MousePheno | increased thymus tumor incidence | 1.13e-06 | 54 | 21 | 4 | MP:0010365 | |
| MousePheno | increased gland tumor incidence | 1.62e-06 | 139 | 21 | 5 | MP:0010288 | |
| MousePheno | abnormal tumor incidence | 2.09e-06 | 635 | 21 | 8 | MP:0002019 | |
| MousePheno | abnormal tumor susceptibility | 2.49e-06 | 650 | 21 | 8 | MP:0002166 | |
| MousePheno | abnormal female meiosis | 6.72e-06 | 84 | 21 | 4 | MP:0005168 | |
| MousePheno | abnormal oogenesis | 6.76e-06 | 186 | 21 | 5 | MP:0001931 | |
| MousePheno | neoplasm | 7.00e-06 | 747 | 21 | 8 | MP:0002006 | |
| MousePheno | increased tumor incidence | 7.92e-06 | 530 | 21 | 7 | MP:0002020 | |
| MousePheno | abnormal meiosis | 2.37e-05 | 241 | 21 | 5 | MP:0001930 | |
| MousePheno | abnormal polar body morphology | 3.21e-05 | 6 | 21 | 2 | MP:0012736 | |
| MousePheno | abnormal DNA repair | 3.78e-05 | 130 | 21 | 4 | MP:0008058 | |
| MousePheno | abnormal female germ cell morphology | 6.61e-05 | 150 | 21 | 4 | MP:0006361 | |
| MousePheno | increased lymphoma incidence | 9.35e-05 | 164 | 21 | 4 | MP:0012431 | |
| MousePheno | abnormal meiotic spindle morphology | 1.17e-04 | 11 | 21 | 2 | MP:0009761 | |
| MousePheno | abnormal double-strand DNA break repair | 1.50e-04 | 70 | 21 | 3 | MP:0010948 | |
| MousePheno | increased hemolymphoid system tumor incidence | 1.68e-04 | 191 | 21 | 4 | MP:0010296 | |
| MousePheno | increased circulating thyroxine level | 2.23e-04 | 15 | 21 | 2 | MP:0005477 | |
| MousePheno | increased organ/body region tumor incidence | 2.46e-04 | 395 | 21 | 5 | MP:0010274 | |
| MousePheno | increased thyroxine level | 2.55e-04 | 16 | 21 | 2 | MP:0005470 | |
| MousePheno | abnormal organ/body region tumor incidence | 2.64e-04 | 401 | 21 | 5 | MP:0013152 | |
| MousePheno | abnormal germ cell morphology | 3.19e-04 | 946 | 21 | 7 | MP:0002208 | |
| MousePheno | abnormal compact bone volume | 3.24e-04 | 18 | 21 | 2 | MP:0010963 | |
| MousePheno | abnormal foam cell morphology | 3.36e-04 | 954 | 21 | 7 | MP:0009840 | |
| MousePheno | increased circulating levels of thyroid hormone | 3.62e-04 | 19 | 21 | 2 | MP:0003350 | |
| MousePheno | abnormal ovary morphology | 4.53e-04 | 451 | 21 | 5 | MP:0001126 | |
| MousePheno | abnormal female reproductive gland morphology | 5.75e-04 | 475 | 21 | 5 | MP:0013324 | |
| MousePheno | abnormal incidence of induced tumors | 6.20e-04 | 269 | 21 | 4 | MP:0013151 | |
| MousePheno | abnormal fibroblast physiology | 6.37e-04 | 271 | 21 | 4 | MP:0020414 | |
| MousePheno | abnormal gametogenesis | 6.75e-04 | 1070 | 21 | 7 | MP:0001929 | |
| MousePheno | abnormal cell differentiation | 8.62e-04 | 795 | 21 | 6 | MP:0005076 | |
| MousePheno | abnormal intracellular organelle physiology | 9.60e-04 | 532 | 21 | 5 | MP:0014241 | |
| MousePheno | abnormal endocrine gland morphology | 1.01e-03 | 1144 | 21 | 7 | MP:0013560 | |
| MousePheno | abnormal female reproductive system physiology | 1.43e-03 | 876 | 21 | 6 | MP:0003699 | |
| MousePheno | abnormal metabolism | 2.01e-03 | 936 | 21 | 6 | MP:0005266 | |
| Domain | zf-C4 | 1.58e-03 | 46 | 24 | 2 | PF00105 | |
| Domain | NUCLEAR_REC_DBD_1 | 1.58e-03 | 46 | 24 | 2 | PS00031 | |
| Domain | Znf_hrmn_rcpt | 1.58e-03 | 46 | 24 | 2 | IPR001628 | |
| Domain | Nuclear_hrmn_rcpt | 1.58e-03 | 46 | 24 | 2 | IPR001723 | |
| Domain | ZnF_C4 | 1.58e-03 | 46 | 24 | 2 | SM00399 | |
| Domain | NUCLEAR_REC_DBD_2 | 1.58e-03 | 46 | 24 | 2 | PS51030 | |
| Domain | - | 1.65e-03 | 47 | 24 | 2 | 1.10.565.10 | |
| Domain | HOLI | 1.72e-03 | 48 | 24 | 2 | SM00430 | |
| Domain | Nucl_hrmn_rcpt_lig-bd | 1.72e-03 | 48 | 24 | 2 | IPR000536 | |
| Domain | Hormone_recep | 1.72e-03 | 48 | 24 | 2 | PF00104 | |
| Domain | - | 2.42e-03 | 57 | 24 | 2 | 3.30.50.10 | |
| Domain | Znf_NHR/GATA | 2.50e-03 | 58 | 24 | 2 | IPR013088 | |
| Domain | TSP_1 | 2.95e-03 | 63 | 24 | 2 | PF00090 | |
| Domain | TSP1 | 3.13e-03 | 65 | 24 | 2 | SM00209 | |
| Domain | TSP1_rpt | 3.13e-03 | 65 | 24 | 2 | IPR000884 | |
| Domain | TSP1 | 3.13e-03 | 65 | 24 | 2 | PS50092 | |
| Domain | PHD | 5.79e-03 | 89 | 24 | 2 | SM00249 | |
| Domain | Znf_PHD | 6.04e-03 | 91 | 24 | 2 | IPR001965 | |
| Domain | ZF_PHD_2 | 6.57e-03 | 95 | 24 | 2 | PS50016 | |
| Domain | ZF_PHD_1 | 6.70e-03 | 96 | 24 | 2 | PS01359 | |
| Domain | Znf_FYVE_PHD | 1.52e-02 | 147 | 24 | 2 | IPR011011 | |
| Domain | - | 1.92e-02 | 449 | 24 | 3 | 3.30.40.10 | |
| Domain | Znf_RING/FYVE/PHD | 2.03e-02 | 459 | 24 | 3 | IPR013083 | |
| Pathway | WP_DNA_IRDAMAGE_AND_CELLULAR_RESPONSE_VIA_ATR | 1.40e-04 | 81 | 18 | 3 | M39490 | |
| Pathway | PID_RXR_VDR_PATHWAY | 4.91e-04 | 26 | 18 | 2 | M162 | |
| Pathway | WP_WNTBETACATENIN_SIGNALING_IN_LEUKEMIA | 4.91e-04 | 26 | 18 | 2 | M39407 | |
| Pubmed | A PML–PPAR-δ pathway for fatty acid oxidation regulates hematopoietic stem cell maintenance. | 5.37e-07 | 2 | 26 | 2 | 22902876 | |
| Pubmed | Multiple roles of FOXJ3 in spermatogenesis: A lesson from Foxj3 conditional knockout mouse models. | 1.81e-06 | 32 | 26 | 3 | 27739607 | |
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | 2.74e-06 | 877 | 26 | 7 | 20211142 | |
| Pubmed | EMSY links the BRCA2 pathway to sporadic breast and ovarian cancer. | 3.22e-06 | 4 | 26 | 2 | 14651845 | |
| Pubmed | Autologous K63 deubiquitylation within the BRCA1-A complex licenses DNA damage recognition. | 5.37e-06 | 5 | 26 | 2 | 35938958 | |
| Pubmed | 8.05e-06 | 6 | 26 | 2 | 25830658 | ||
| Pubmed | 8.05e-06 | 6 | 26 | 2 | 10610177 | ||
| Pubmed | SETDB1 Links the Meiotic DNA Damage Response to Sex Chromosome Silencing in Mice. | 1.50e-05 | 8 | 26 | 2 | 30393076 | |
| Pubmed | RNF168-mediated localization of BARD1 recruits the BRCA1-PALB2 complex to DNA damage. | 1.50e-05 | 8 | 26 | 2 | 34408138 | |
| Pubmed | Stabilization of mutant BRCA1 protein confers PARP inhibitor and platinum resistance. | 1.93e-05 | 9 | 26 | 2 | 24085845 | |
| Pubmed | 2.39e-05 | 808 | 26 | 6 | 20412781 | ||
| Pubmed | Expression of cellular oncogenes during embryonic and fetal development of the mouse. | 2.41e-05 | 10 | 26 | 2 | 6594688 | |
| Pubmed | TOPORS-mediated RAD51 SUMOylation facilitates homologous recombination repair. | 2.94e-05 | 11 | 26 | 2 | 35061896 | |
| Pubmed | 4.17e-05 | 13 | 26 | 2 | 29499138 | ||
| Pubmed | 1.12e-04 | 21 | 26 | 2 | 11940593 | ||
| Pubmed | BRCA1- and BRCA2-Associated Hereditary Breast and Ovarian Cancer | 1.12e-04 | 21 | 26 | 2 | 20301425 | |
| Pubmed | 1.86e-04 | 149 | 26 | 3 | 25184681 | ||
| Pubmed | 1.86e-04 | 27 | 26 | 2 | 8595891 | ||
| Pubmed | NANOG-dependent function of TET1 and TET2 in establishment of pluripotency. | 1.86e-04 | 27 | 26 | 2 | 23395962 | |
| Pubmed | Polymorphism in the IL18 gene and epithelial ovarian cancer in non-Hispanic white women. | 2.75e-04 | 170 | 26 | 3 | 19064572 | |
| Pubmed | 2.80e-04 | 33 | 26 | 2 | 36522157 | ||
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | 3.14e-04 | 444 | 26 | 4 | 34795231 | |
| Pubmed | 5.45e-04 | 46 | 26 | 2 | 30419336 | ||
| Pubmed | 5.69e-04 | 47 | 26 | 2 | 32892421 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 6.26e-04 | 954 | 26 | 5 | 36373674 | |
| Pubmed | Six1 homeoprotein drives myofiber type IIA specialization in soleus muscle. | 6.44e-04 | 50 | 26 | 2 | 27597886 | |
| Pubmed | CRL4 complex regulates mammalian oocyte survival and reprogramming by activation of TET proteins. | 7.23e-04 | 53 | 26 | 2 | 24357321 | |
| GeneFamily | Nuclear hormone receptors | 1.07e-03 | 49 | 18 | 2 | 71 | |
| GeneFamily | Ring finger proteins|Tripartite motif containing|ARF GTPase family | 3.96e-03 | 95 | 18 | 2 | 59 | |
| ToppCell | LPS_only-Endothelial-Endothelial-FOXM1|LPS_only / Treatment groups by lineage, cell group, cell type | 9.34e-08 | 197 | 26 | 5 | 038fd92750257d43d5e980fd06d77742b543f11a | |
| ToppCell | Dividing_Macrophages-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 3.09e-06 | 175 | 26 | 4 | 0a8bf455babb3271aa00642199fb58b0b02dc3ac | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-Alveolar_macrophage_proliferating_L.1.0.7.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.84e-06 | 196 | 26 | 4 | eb8c9a4a5eb21d43ff7b25deae5896c236f669b9 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.94e-06 | 197 | 26 | 4 | 76b61e60a757e58b465569538e632d6d9953e89a | |
| ToppCell | Sigmoid-T_cell-cycling_gd_T|T_cell / Region, Cell class and subclass | 5.25e-06 | 200 | 26 | 4 | 4e489ecf472857357d45e9f6c7a812aa48b72ebf | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-Like|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.55e-05 | 110 | 26 | 3 | c80d1c3df75648e2c8f6832279c2acca63d76681 | |
| ToppCell | Control-Epithelial_alveolar-AT_1-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.97e-05 | 138 | 26 | 3 | 611fe0fb284e12678f9c47a0bdbfc367a93c52b3 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-Like-AT2_Progenitor|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.10e-05 | 151 | 26 | 3 | c06a54afe918b14f885d6a85fbcf81e80f33afae | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.84e-05 | 155 | 26 | 3 | 969fc4c98a96bf2f436e8e63d4deb2183ef3b864 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.00e-04 | 156 | 26 | 3 | b3f10cd044f24807576e7d56e51df7064dbf6c50 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-04 | 157 | 26 | 3 | 1ccb07a38d3fb606ee5fbc0437655f49baaaa62c | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c09-GZMK-FOS_l|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.04e-04 | 158 | 26 | 3 | 5775246e192629058ed89fb56031bdf4cbb9c15c | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-FOXM1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.14e-04 | 163 | 26 | 3 | 5285318c52aa31c9b22dc2ffff078e32e408604d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.14e-04 | 163 | 26 | 3 | 3f434015c0cbefb31eeda133c34f75384c5f7e22 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.18e-04 | 165 | 26 | 3 | eec2d327c94832d1390314c93ef6a2be4648478b | |
| ToppCell | wk_15-18-Epithelial-Airway_epithelial_progenitor-epi-stalk_intermediate|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.18e-04 | 165 | 26 | 3 | 4297588f809e8a8275ab1a6ed99daac7ad93bd61 | |
| ToppCell | Dividing_Macrophages-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 1.20e-04 | 166 | 26 | 3 | c503036f3c19ef186e1e62c9643c49dea3827f51 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.20e-04 | 166 | 26 | 3 | 2642544070564debe2deb2938d2c33997bf5ef02 | |
| ToppCell | 10x5'-Liver-Hematopoietic_progenitors|Liver / Manually curated celltypes from each tissue | 1.20e-04 | 166 | 26 | 3 | ae967570248cf86ca3ddf55e33bcbb3e4e3684bc | |
| ToppCell | 10x5'-Liver-Hematopoietic_progenitors-Cycling_pre-Myeloid-2|Liver / Manually curated celltypes from each tissue | 1.20e-04 | 166 | 26 | 3 | a176e87aa6eec81d1fb79a028f759182d11b567d | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-04 | 167 | 26 | 3 | 50c29ea660bf07b890e4ac1a1985d0761d863dee | |
| ToppCell | 390C-Myeloid-Dendritic-cDC_proliferating_1|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.25e-04 | 168 | 26 | 3 | 2082b15fc7935a211f1c61506b305af5501a21ad | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-04 | 168 | 26 | 3 | d35944fd9fea9934ce1e76b2b35d48e2300cca61 | |
| ToppCell | Dividing_Macrophages-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 1.27e-04 | 169 | 26 | 3 | eb0c993ef2eea73bc4881182520922ce9ae9368f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-04 | 169 | 26 | 3 | e7514956b2e4298222ec443f98b2f5289451786e | |
| ToppCell | Dividing_Macrophages-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 1.27e-04 | 169 | 26 | 3 | bc859a103cad567caf50c3c3882d2d2017807c73 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-FOXM1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.27e-04 | 169 | 26 | 3 | e0607af8ae8609d43e26ff2a2cab92650bfcd5b7 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-04 | 169 | 26 | 3 | b253a4a50c06d36228fcd5d856c57202cbac158f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.32e-04 | 171 | 26 | 3 | 55c7bf7211587fa08df13c0a4ff5b78a85d5439e | |
| ToppCell | 390C-Myeloid-Dendritic-cDC_proliferating_1|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.34e-04 | 172 | 26 | 3 | 6fcc16f1067672967ecbcdfdc727649ae9891dd9 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.36e-04 | 173 | 26 | 3 | a25459b8140b0dbcb73e3b4cc1407b679229f25c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.38e-04 | 174 | 26 | 3 | 84da9faff088d05233183b425385beb054c92d1b | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.38e-04 | 174 | 26 | 3 | 7b318796728001c17b4043d2b033330c7be40c78 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.38e-04 | 174 | 26 | 3 | c26eac176e9b0cba385630fdc60e0314a4e4caac | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.38e-04 | 174 | 26 | 3 | dbb4e1a6c3319ce40f81bfd2d1745a88a2cc412e | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.38e-04 | 174 | 26 | 3 | 46cbb462173a684ceb9e680f9259dc3b133763f7 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.41e-04 | 175 | 26 | 3 | 876cea684faf42ff3eb4623ad6d7a1fb1276ee02 | |
| ToppCell | 367C-Myeloid-Dendritic-cDC_proliferating_1|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.41e-04 | 175 | 26 | 3 | 6b4e841bde6cfa4956e1a0231672cea20f11210c | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_DCN|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.43e-04 | 176 | 26 | 3 | 08f94b78b27feeb113dbfadbfa7fe34d08b2809b | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.46e-04 | 177 | 26 | 3 | 73ba0f0b4b33f10e9f036d6d9befa48a1258e682 | |
| ToppCell | 367C-Myeloid-Dendritic-cDC_proliferating_1|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.46e-04 | 177 | 26 | 3 | ba701d3c90722d8bff70d0fa651899305cdad257 | |
| ToppCell | Dividing_Macrophages-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 1.48e-04 | 178 | 26 | 3 | 1893fadac2ec3d5de0a641e57b7b2f962012a9ba | |
| ToppCell | Dividing_Macrophages-Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 1.48e-04 | 178 | 26 | 3 | 6557688c6790a5bcc3b9aea5b8789cf9506b3c54 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-04 | 179 | 26 | 3 | 6f51a4580c06fc55cc764052c9b26f7c55660282 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-04 | 179 | 26 | 3 | a6ce1fa338d4905bd6afef00763ac83e916a0b37 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-04 | 179 | 26 | 3 | f14440f6ce9b4fcdd4bcb2488b949f9a0e17bc23 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-plasmablast-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.51e-04 | 179 | 26 | 3 | 021d782134126c6f7dce6b6ea50cc54bdaa39987 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.53e-04 | 180 | 26 | 3 | 401df9cddcbca1eb8f0d2687bcacd98e95dc1493 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-FOXM1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.53e-04 | 180 | 26 | 3 | 334e2b1f6eb7d4ece20b1c7b02107863f913237f | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.53e-04 | 180 | 26 | 3 | f8a15c13d85c1bbbf86ce49bb6f86c368ddf22df | |
| ToppCell | facs-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.56e-04 | 181 | 26 | 3 | cd4f744b6b64ba6c22ec07afd1d3058a2546909d | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Hematopoietic-Megakaryocytic-Megakaryocyte|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.56e-04 | 181 | 26 | 3 | c5843b89f3d362e236ff76c3279518a2fdfc1f75 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Hematopoietic-Megakaryocytic|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.56e-04 | 181 | 26 | 3 | 14c2dd946e89ba578711c2d25935b6b3d319b701 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.56e-04 | 181 | 26 | 3 | 269b39ac65790061d54eab47a8eeb024403f0348 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Hematopoietic-Megakaryocytic-Megakaryocyte-Mega|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.56e-04 | 181 | 26 | 3 | fcefb5902416c004631f4f8dd5c8f99fe3bd90bc | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-Alveolar_macrophage_proliferating_L.1.0.7.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.56e-04 | 181 | 26 | 3 | 73b1b59810f60e3e39ca1d5073a5a0d4f5377e6e | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_low-phase|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.56e-04 | 181 | 26 | 3 | e0c46e2d52c97893e5894a51d2699e8a8a11eefc | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Hematopoietic|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.56e-04 | 181 | 26 | 3 | 9dc0563453e24c9d1d975e2e0e1e272487e19908 | |
| ToppCell | 10x5'-bone_marrow-Hematopoietic_progenitors-Cycling_pre-Myeloid-1|bone_marrow / Manually curated celltypes from each tissue | 1.56e-04 | 181 | 26 | 3 | ccd0ed30cea3fb41d34f28b3e8d80a94493bef3c | |
| ToppCell | facs-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.56e-04 | 181 | 26 | 3 | c8395ae872aa80b3ae1ab7c53e57b3ca15aeb0e2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.58e-04 | 182 | 26 | 3 | 336cd05e46a741185ce3c59ee67a4b07fa6a5101 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-brush_cell_of_trachebronchial_tree-Tuft|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.58e-04 | 182 | 26 | 3 | d1c3cc2942faec7527a3c25869fd65c17899e5e4 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Lymphocytic-Proliferating_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-04 | 182 | 26 | 3 | fe46819c153a81911864473badc794f243705f98 | |
| ToppCell | 3'_v3-bone_marrow-Hematopoietic_progenitors-Progenitor_Myeloid|bone_marrow / Manually curated celltypes from each tissue | 1.58e-04 | 182 | 26 | 3 | 6745d464c3ff289726aa8164e9a43f407f8e4380 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-brush_cell_of_trachebronchial_tree|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.58e-04 | 182 | 26 | 3 | 92f83f29e358000cd86a709eb8b6199761ffe8bd | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4/8-lo-Cycling_T|Liver / Manually curated celltypes from each tissue | 1.58e-04 | 182 | 26 | 3 | 81557cdc88777f3bd4e1dd18a760b08fc29122ef | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Lymphocytic-T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-04 | 182 | 26 | 3 | 3948422707d6d5e021bcd7158e2eb69143613f62 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-brush_cell_of_trachebronchial_tree-Tuft-Tuft_L.0.7.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.58e-04 | 182 | 26 | 3 | 02baca9a72c7b559c3e452693b3b134af804c868 | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-5|TCGA-Liver / Sample_Type by Project: Shred V9 | 1.61e-04 | 183 | 26 | 3 | f604a8b62c7088fad8365dbf8d910fc980bd3ba8 | |
| ToppCell | 367C-Lymphocytic-NK_cells-Proliferating_NK_cell|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.61e-04 | 183 | 26 | 3 | a716b446c2bf5aa294b8f580aa845098fae76354 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.63e-04 | 184 | 26 | 3 | a6dee97ee4ef9d89e11d17339e0dadaea1210ce5 | |
| ToppCell | IIF-Lymphocyte-T_NK-T_NK_proliferative|IIF / Disease, Lineage and Cell Type | 1.63e-04 | 184 | 26 | 3 | ab8b45ce40e8c5f66e5c23332a591b4f9cba4ce1 | |
| ToppCell | Dividing_Macrophages-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 1.63e-04 | 184 | 26 | 3 | f15ce786d25c6546804a6d1efcc2ad645f2ef54e | |
| ToppCell | Control-T_cells-Cycling_NK/T_cells|Control / group, cell type (main and fine annotations) | 1.66e-04 | 185 | 26 | 3 | 9766216b41ee62bbac4caa25cb98ec5627a24075 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.66e-04 | 185 | 26 | 3 | 30e041d6f6e310d64809e9d6d93cd30052972f3b | |
| ToppCell | URO-Lymphocyte-T_NK-T_NK_proliferative|URO / Disease, Lineage and Cell Type | 1.66e-04 | 185 | 26 | 3 | 0ae9c646679c69a553eda670aef0e0495feb0286 | |
| ToppCell | COVID-19-Fibroblasts-Adventitial_FB|COVID-19 / group, cell type (main and fine annotations) | 1.66e-04 | 185 | 26 | 3 | a5aebf2b9b05b550d021272731d68af9a6b1229d | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_proliferating|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.69e-04 | 186 | 26 | 3 | 5d527050cd554cc46c6d8dcb7981900725d79fc6 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_proliferating-Lymphatic_EC_proliferating_L.2.5.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.69e-04 | 186 | 26 | 3 | ee1c3e2adfa2900542200a218746b576c7ed10dc | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.71e-04 | 187 | 26 | 3 | cefa211ef224e803ea9467882e2ca74d0b1492f1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.71e-04 | 187 | 26 | 3 | 057569c9437219ecc396aa6e673b1178a2273837 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-04 | 187 | 26 | 3 | 4e553721fa5598cb211f44e3226280b7e6885484 | |
| ToppCell | droplet-Spleen-nan-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-04 | 187 | 26 | 3 | c81d11d9fdc22dc39222f62c2888025c2e8c3e65 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-04 | 187 | 26 | 3 | d36e7fc6125e7a4310499365022d38f34b757a73 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-04 | 187 | 26 | 3 | 827eae63fabf6892a82ce7779b5f395958d3d628 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.71e-04 | 187 | 26 | 3 | e41e39fd3791acf8ae5376cc5061e196d96868ae | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.71e-04 | 187 | 26 | 3 | 9351fa87b69a951af85b10bf91fe9b1cce8c0517 | |
| ToppCell | Multiple_Sclerosis-Lymphocyte-T_NK-T_NK_proliferative|Multiple_Sclerosis / Disease, Lineage and Cell Type | 1.74e-04 | 188 | 26 | 3 | 6c05797a5d0635d89ffcf4aca52178687129ccb4 | |
| ToppCell | facs-Kidney-nan-3m-Mesenchymal-mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-04 | 189 | 26 | 3 | 302b950a6ad578f8aeff7ea6fd15fe631225287d | |
| ToppCell | NS-critical-d_0-4-Lymphoid-NKT-proliferating|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.77e-04 | 189 | 26 | 3 | d6bd46abb072b13a6b72f1ca25d19f218cceb1ff | |
| ToppCell | facs-Kidney-nan-3m-Mesenchymal-mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-04 | 189 | 26 | 3 | a5306561026e4dfcc39beeb785e5108ac595d136 | |
| ToppCell | Control-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.77e-04 | 189 | 26 | 3 | 1e1499b062d9c647c8f38b0c4e0d871d159be5dd | |
| ToppCell | facs-Kidney-nan-3m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-04 | 189 | 26 | 3 | 381058f55908f84375b54601d617389ef43ab855 | |
| ToppCell | Dividing_Macrophages-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 1.77e-04 | 189 | 26 | 3 | d4e88a3e50499d683e3db38aee04490146fe30bb | |
| ToppCell | Int-URO-Lymphocyte-T_NK-T_NK_proliferative|Int-URO / Disease, Lineage and Cell Type | 1.79e-04 | 190 | 26 | 3 | 005967c540418b85311308072a07c684f4296aef | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-Cycling_Natural_Killer_Cell_/_Natural_Killer_T_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.79e-04 | 190 | 26 | 3 | 185ae04c68f825cd346aa65072cc5da6a39dff4a | |
| ToppCell | NS-critical-d_07-13-Epithelial-FOXN4+|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.79e-04 | 190 | 26 | 3 | 7be0f2ff86ca8500a43e0d44e5e292530f9ba0bb | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell-T_cells_proliferating-T_cells_proliferating_L.1.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.79e-04 | 190 | 26 | 3 | b69940d16685249167d4c2cf6ad8237ccf6f7590 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-Cycling_Natural_Killer_Cell_/_Natural_Killer_T_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.79e-04 | 190 | 26 | 3 | e38dc41f2e79e3bd51326581c6ebe51927edb549 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD4/8-lo-Cycling_T|GI_small-bowel / Manually curated celltypes from each tissue | 1.82e-04 | 191 | 26 | 3 | e642fa7395c05fb53324c9d46bbc52f89fc9673f | |
| Drug | Propofol [2078-54-8]; Down 200; 22.4uM; PC3; HT_HG-U133A | 2.02e-06 | 195 | 25 | 5 | 6707_DN | |
| Drug | N-aminoimidazole | 3.47e-06 | 3 | 25 | 2 | CID005273583 | |
| Drug | DB04006 | 1.12e-05 | 40 | 25 | 3 | CID005289179 | |
| Drug | Hyoscyamine (L) [101-31-5]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 5.40e-05 | 192 | 25 | 4 | 2271_DN | |
| Drug | Gly-His-Lys acetate salt; Down 200; 1uM; MCF7; HT_HG-U133A | 5.62e-05 | 194 | 25 | 4 | 6575_DN | |
| Drug | Medrysone [2668-66-8]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 5.62e-05 | 194 | 25 | 4 | 4727_DN | |
| Drug | Pregnenolone [145-13-1]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 5.85e-05 | 196 | 25 | 4 | 4802_DN | |
| Drug | Lovastatin [75330-75-5]; Down 200; 9.8uM; HL60; HT_HG-U133A | 5.96e-05 | 197 | 25 | 4 | 2494_DN | |
| Drug | Lomefloxacin hydrochloride [98079-52-8]; Down 200; 10.4uM; MCF7; HT_HG-U133A | 5.96e-05 | 197 | 25 | 4 | 3620_DN | |
| Drug | Ginkgolide A [15291-75-5]; Up 200; 9.8uM; HL60; HT_HG-U133A | 5.96e-05 | 197 | 25 | 4 | 1324_UP | |
| Drug | Ajmalicine hydrochloride [4373-34-6]; Up 200; 10.2uM; PC3; HT_HG-U133A | 5.96e-05 | 197 | 25 | 4 | 6360_UP | |
| Drug | Sparteine (-) [90-39-1]; Down 200; 17uM; PC3; HT_HG-U133A | 6.08e-05 | 198 | 25 | 4 | 4568_DN | |
| Drug | Sv 1 | 1.56e-04 | 17 | 25 | 2 | CID000209652 | |
| Drug | AC1OC6D1 | 1.98e-04 | 104 | 25 | 3 | CID006368594 | |
| Drug | AC1O5RQH | 3.70e-04 | 26 | 25 | 2 | CID006439470 | |
| Drug | Nexus | 6.02e-04 | 152 | 25 | 3 | CID000098527 | |
| Drug | treprostinil sodium | 7.94e-04 | 38 | 25 | 2 | CID000054786 | |
| Drug | Rifabutin [72559-06-9]; Up 200; 4.8uM; MCF7; HT_HG-U133A | 9.06e-04 | 175 | 25 | 3 | 3873_UP | |
| Drug | CPG-oligonucleotide | 1.05e-03 | 184 | 25 | 3 | ctd:C408982 | |
| Drug | Amoxicillin [26787-78-0]; Down 200; 11uM; MCF7; HT_HG-U133A | 1.06e-03 | 185 | 25 | 3 | 2620_DN | |
| Drug | Etoposide [33419-42-0]; Down 200; 6.8uM; MCF7; HT_HG-U133A | 1.06e-03 | 185 | 25 | 3 | 3241_DN | |
| Drug | Loperamide hydrochloride [34552-83-5]; Up 200; 7.8uM; MCF7; HT_HG-U133A | 1.08e-03 | 186 | 25 | 3 | 1533_UP | |
| Drug | rapamycin, Streptomyces hygroscepicus; Up 200; 0.1uM; PC3; HT_HG-U133A | 1.11e-03 | 188 | 25 | 3 | 5980_UP | |
| Drug | 2-propylpentanoic acid; Down 200; 10000uM; HL60; HG-U133A | 1.13e-03 | 189 | 25 | 3 | 410_DN | |
| Drug | Estradiol-17 beta [50-28-2]; Down 200; 14.6uM; PC3; HT_HG-U133A | 1.15e-03 | 190 | 25 | 3 | 6718_DN | |
| Drug | Chlorprothixene hydrochloride [6469-93-8]; Up 200; 11.4uM; MCF7; HT_HG-U133A | 1.17e-03 | 191 | 25 | 3 | 2627_UP | |
| Drug | Meticrane [1084-65-7]; Up 200; 14.6uM; PC3; HT_HG-U133A | 1.18e-03 | 192 | 25 | 3 | 1792_UP | |
| Drug | Norethynodrel [68-23-5]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 1.18e-03 | 192 | 25 | 3 | 1696_UP | |
| Drug | Dilazep dihydrochloride [20153-98-4]; Up 200; 6uM; PC3; HT_HG-U133A | 1.18e-03 | 192 | 25 | 3 | 7364_UP | |
| Drug | Cyclobenzaprine hydrochloride [6202-23-9]; Up 200; 12.8uM; HL60; HT_HG-U133A | 1.18e-03 | 192 | 25 | 3 | 1332_UP | |
| Drug | Orlistat; Up 200; 10uM; PC3; HT_HG-U133A | 1.18e-03 | 192 | 25 | 3 | 6388_UP | |
| Drug | Sulfadiazine [68-35-9]; Down 200; 16uM; HL60; HT_HG-U133A | 1.20e-03 | 193 | 25 | 3 | 1852_DN | |
| Drug | Rapamycin; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.20e-03 | 193 | 25 | 3 | 4431_DN | |
| Drug | Diethylstilbestrol [56-53-1]; Up 200; 15uM; MCF7; HT_HG-U133A | 1.20e-03 | 193 | 25 | 3 | 3429_UP | |
| Drug | Clotrimazole [23593-75-1]; Down 200; 11.6uM; PC3; HT_HG-U133A | 1.20e-03 | 193 | 25 | 3 | 5726_DN | |
| Drug | Isoxsuprine hydrochloride [579-56-6]; Down 200; 11.8uM; PC3; HT_HG-U133A | 1.20e-03 | 193 | 25 | 3 | 4205_DN | |
| Drug | Epirubicin | 1.21e-03 | 47 | 25 | 2 | ctd:D015251 | |
| Drug | Pimethixene maleate [13187-06-9]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 1.22e-03 | 194 | 25 | 3 | 7468_DN | |
| Drug | Cefmetazole sodium salt [56796-39-5]; Down 200; 8.2uM; HL60; HT_HG-U133A | 1.22e-03 | 194 | 25 | 3 | 2524_DN | |
| Drug | Lomefloxacin hydrochloride [98079-52-8]; Down 200; 10.4uM; PC3; HT_HG-U133A | 1.22e-03 | 194 | 25 | 3 | 4281_DN | |
| Drug | LY 294002; Up 200; 10uM; PC3; HT_HG-U133A | 1.22e-03 | 194 | 25 | 3 | 1239_UP | |
| Drug | Sulfamonomethoxine [1220-83-3]; Down 200; 14.2uM; HL60; HT_HG-U133A | 1.22e-03 | 194 | 25 | 3 | 2742_DN | |
| Drug | Delcorine; Down 200; 8.4uM; PC3; HT_HG-U133A | 1.22e-03 | 194 | 25 | 3 | 4275_DN | |
| Drug | Tetrandrine [518-34-3]; Down 200; 6.4uM; HL60; HT_HG-U133A | 1.22e-03 | 194 | 25 | 3 | 2520_DN | |
| Drug | Metoclopramide monohydrochloride [7232-21-5]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 1.22e-03 | 194 | 25 | 3 | 3625_DN | |
| Drug | Felodipine [72509-76-3]; Down 200; 10.4uM; PC3; HT_HG-U133A | 1.22e-03 | 194 | 25 | 3 | 6695_DN | |
| Drug | Cyanocobalamin [68-19-9]; Down 200; 3uM; PC3; HT_HG-U133A | 1.22e-03 | 194 | 25 | 3 | 4572_DN | |
| Drug | Fosfosal [6064-83-1]; Down 200; 18.4uM; PC3; HT_HG-U133A | 1.22e-03 | 194 | 25 | 3 | 4239_DN | |
| Drug | (-)-Quinpirole hydrochloride [85760-74-3]; Down 200; 15.6uM; MCF7; HT_HG-U133A | 1.22e-03 | 194 | 25 | 3 | 3539_DN | |
| Drug | Cholecalciferol [67-97-0]; Down 200; 10.4uM; PC3; HT_HG-U133A | 1.22e-03 | 194 | 25 | 3 | 6656_DN | |
| Drug | Carbamazepine [298-46-4]; Up 200; 17uM; PC3; HT_HG-U133A | 1.22e-03 | 194 | 25 | 3 | 1805_UP | |
| Drug | Sertaconazole nitrate [99592-39-9]; Down 200; 8uM; HL60; HT_HG-U133A | 1.22e-03 | 194 | 25 | 3 | 6128_DN | |
| Drug | Etifenin [63245-28-3]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 1.22e-03 | 194 | 25 | 3 | 4117_UP | |
| Drug | Skimmianine [83-95-4]; Down 200; 15.4uM; HL60; HT_HG-U133A | 1.22e-03 | 194 | 25 | 3 | 2504_DN | |
| Drug | prochlorperazine dimaleate salt; Down 200; 10uM; HL60; HT_HG-U133A | 1.24e-03 | 195 | 25 | 3 | 6174_DN | |
| Drug | Atovaquone [95233-18-4]; Down 200; 11uM; PC3; HT_HG-U133A | 1.24e-03 | 195 | 25 | 3 | 4201_DN | |
| Drug | Nafronyl oxalate [3200-06-4]; Down 200; 8.4uM; HL60; HT_HG-U133A | 1.24e-03 | 195 | 25 | 3 | 1267_DN | |
| Drug | Delcorine; Down 200; 8.4uM; MCF7; HT_HG-U133A | 1.24e-03 | 195 | 25 | 3 | 4737_DN | |
| Drug | Tyloxapol [25301-02-4]; Down 200; 4uM; PC3; HT_HG-U133A | 1.24e-03 | 195 | 25 | 3 | 4611_DN | |
| Drug | Ticarcillin sodium [4697-14-7]; Down 200; 9.4uM; HL60; HT_HG-U133A | 1.24e-03 | 195 | 25 | 3 | 6146_DN | |
| Drug | PHA-00767505E [723337-45-9]; Up 200; 10uM; PC3; HT_HG-U133A | 1.24e-03 | 195 | 25 | 3 | 6545_UP | |
| Drug | Hemicholinium bromide [312-45-8]; Down 200; 7uM; PC3; HT_HG-U133A | 1.24e-03 | 195 | 25 | 3 | 6739_DN | |
| Drug | Cytisine (-) [485-35-8]; Down 200; 21uM; PC3; HT_HG-U133A | 1.24e-03 | 195 | 25 | 3 | 5739_DN | |
| Drug | Lidoflazine [3416-26-0]; Down 200; 8.2uM; MCF7; HT_HG-U133A | 1.24e-03 | 195 | 25 | 3 | 3201_DN | |
| Drug | Ramipril [87333-19-5]; Up 200; 9.6uM; PC3; HT_HG-U133A | 1.24e-03 | 195 | 25 | 3 | 7144_UP | |
| Drug | 0173570-0000 [211245-44-2]; Down 200; 1uM; PC3; HT_HG-U133A | 1.26e-03 | 196 | 25 | 3 | 7391_DN | |
| Drug | Benzbromarone [3562-84-3]; Down 200; 9.4uM; PC3; HT_HG-U133A | 1.26e-03 | 196 | 25 | 3 | 6669_DN | |
| Drug | Ascorbic acid [50-81-7]; Up 200; 22.4uM; MCF7; HT_HG-U133A | 1.26e-03 | 196 | 25 | 3 | 5407_UP | |
| Drug | Betazole hydrochloride; Down 200; 27uM; PC3; HT_HG-U133A | 1.26e-03 | 196 | 25 | 3 | 6344_DN | |
| Drug | Azapropazone [13539-59-8]; Down 200; 13.4uM; PC3; HT_HG-U133A | 1.26e-03 | 196 | 25 | 3 | 7277_DN | |
| Drug | Gossypol [303-45-7]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 1.26e-03 | 196 | 25 | 3 | 3637_DN | |
| Drug | Corynanthine hydrochloride [66634-44-4]; Down 200; 10.2uM; PC3; HT_HG-U133A | 1.26e-03 | 196 | 25 | 3 | 4227_DN | |
| Drug | Ritodrine hydrochloride [23239-51-2]; Down 200; 12.4uM; PC3; HT_HG-U133A | 1.26e-03 | 196 | 25 | 3 | 4619_DN | |
| Drug | Evoxine [522-11-2]; Down 200; 11.6uM; HL60; HT_HG-U133A | 1.26e-03 | 196 | 25 | 3 | 2186_DN | |
| Drug | Stachydrine hydrochloride; Down 200; 22.2uM; PC3; HT_HG-U133A | 1.26e-03 | 196 | 25 | 3 | 4469_DN | |
| Drug | Allantoin [97-59-6]; Up 200; 25.2uM; PC3; HT_HG-U133A | 1.26e-03 | 196 | 25 | 3 | 5052_UP | |
| Drug | Nomegestrol acetate [58652-20-3]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 1.26e-03 | 196 | 25 | 3 | 5461_UP | |
| Drug | 5194442; Up 200; 20uM; PC3; HT_HG-U133A | 1.26e-03 | 196 | 25 | 3 | 6594_UP | |
| Drug | 2-propylpentanoic acid; Up 200; 200uM; MCF7; HT_HG-U133A | 1.26e-03 | 196 | 25 | 3 | 1639_UP | |
| Drug | Dimethadione [695-53-4]; Down 200; 31uM; HL60; HT_HG-U133A | 1.26e-03 | 196 | 25 | 3 | 3029_DN | |
| Drug | Fluoxetine hydrochloride [59333-67-4]; Down 200; 11.6uM; PC3; HT_HG-U133A | 1.26e-03 | 196 | 25 | 3 | 6757_DN | |
| Drug | Naftifine hydrochloride [65473-14-5]; Down 200; 12.4uM; HL60; HT_HG-U133A | 1.26e-03 | 196 | 25 | 3 | 2974_DN | |
| Drug | PF-00539745-00 [351321-33-0]; Up 200; 10uM; PC3; HT_HG-U133A | 1.26e-03 | 196 | 25 | 3 | 5979_UP | |
| Drug | Foliosidine [2520-38-9]; Down 200; 13uM; MCF7; HT_HG-U133A | 1.26e-03 | 196 | 25 | 3 | 6057_DN | |
| Drug | Acebutolol hydrochloride [34381-68-5]; Down 200; 10.8uM; PC3; HT_HG-U133A | 1.26e-03 | 196 | 25 | 3 | 6631_DN | |
| Disease | cup-to-disc ratio measurement | 2.68e-05 | 430 | 25 | 5 | EFO_0006939 | |
| Disease | BREAST CANCER | 1.43e-04 | 21 | 25 | 2 | 114480 | |
| Disease | Malignant tumor of breast | 2.39e-04 | 27 | 25 | 2 | cv:C0006142 | |
| Disease | Breast neoplasm | 2.39e-04 | 27 | 25 | 2 | cv:C1458155 | |
| Disease | Familial cancer of breast | 2.39e-04 | 27 | 25 | 2 | cv:C0346153 | |
| Disease | breast cancer (is_implicated_in) | 2.73e-04 | 150 | 25 | 3 | DOID:1612 (is_implicated_in) | |
| Disease | response to angiotensin receptor blocker | 2.95e-04 | 30 | 25 | 2 | EFO_0010735 | |
| Disease | Adult Medulloblastoma | 6.09e-04 | 43 | 25 | 2 | C0278876 | |
| Disease | Childhood Medulloblastoma | 6.09e-04 | 43 | 25 | 2 | C0278510 | |
| Disease | Melanotic medulloblastoma | 6.09e-04 | 43 | 25 | 2 | C1275668 | |
| Disease | Medullomyoblastoma | 6.09e-04 | 43 | 25 | 2 | C0205833 | |
| Disease | Desmoplastic Medulloblastoma | 6.09e-04 | 43 | 25 | 2 | C0751291 | |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 6.67e-04 | 45 | 25 | 2 | DOID:3748 (is_implicated_in) | |
| Disease | Liver carcinoma | 8.18e-04 | 507 | 25 | 4 | C2239176 | |
| Disease | Medulloblastoma | 8.23e-04 | 50 | 25 | 2 | C0025149 | |
| Disease | physical activity measurement | 1.14e-03 | 245 | 25 | 3 | EFO_0008002 | |
| Disease | melanoma | 1.18e-03 | 248 | 25 | 3 | C0025202 | |
| Disease | renal cell carcinoma (is_implicated_in) | 1.56e-03 | 69 | 25 | 2 | DOID:4450 (is_implicated_in) | |
| Disease | small cell lung carcinoma | 2.09e-03 | 80 | 25 | 2 | EFO_0000702 | |
| Disease | treatment-resistant hypertension | 3.84e-03 | 109 | 25 | 2 | EFO_1002006 | |
| Disease | bone density | 4.19e-03 | 388 | 25 | 3 | EFO_0003923 | |
| Disease | spine bone mineral density | 4.55e-03 | 119 | 25 | 2 | EFO_0007701 | |
| Disease | cranial vault morphology measurement | 4.70e-03 | 121 | 25 | 2 | EFO_0009278 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SNSKKKRQKKQNTSC | 626 | Q2TB18 | |
| KRQKKQNTSCSKNRG | 631 | Q2TB18 | |
| LKKKMCASQRKQSCQ | 231 | Q8WWL7 | |
| CSQQSSECSRKKRKV | 281 | Q8N7B1 | |
| KQLKLCQLSQFKSRC | 1741 | Q8N6G6 | |
| QTVSKKNKRKNKATC | 156 | P38432 | |
| KCKSKQLCRSQSLLL | 501 | Q5TB30 | |
| RTFLKSSFQKKCQKR | 1041 | Q9H3R0 | |
| SKTNTICKKCAQNVK | 51 | Q5HYJ3 | |
| SKLRCQLAKKKQSET | 656 | O75330 | |
| CFSKCRTKNLQKVRT | 311 | P51587 | |
| SECLKKLQKCNSKSQ | 76 | O15145 | |
| KASQCNVSLKKQRSR | 26 | O15194 | |
| IKQVNKCTKNRLASR | 86 | P00540 | |
| CERSCKIQKKNRNKC | 111 | Q03181 | |
| KRKCSQTQCPRKVIK | 476 | P29590 | |
| NKRWSDKVICKQKRC | 106 | P78539 | |
| NRKNSHQICKKRKCE | 611 | Q8NFU7 | |
| LAKSSKCNRNKQSKL | 666 | Q96JN2 | |
| LRKTCKSINECKVQK | 111 | Q3SXZ3 | |
| ASVRNICSKKQKKSA | 271 | Q8N412 | |
| TRKCTVQRKKCQKGE | 196 | Q9BXY4 | |
| QCSKCKKTTRQRNLK | 51 | A0A3B3IT33 | |
| QCPVCRSIKKKNTNK | 141 | Q15326 | |
| KITRNQCQLCRFKKC | 101 | P10827 | |
| GLQKTKTKQSNRAKC | 56 | Q96RL1 | |
| KSQRCSDKRSKNTKL | 456 | Q9Y2L8 |